Chandra Belani
Hematology & Oncology · Hershey, PANPI 1659343895
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $98,130 of the $149,041 with a category attached, or 65.8%. Genentech USA, Inc. accounts for 82.6% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $112,958 and has fallen 82.9% since, to $19,319 in 2023. Among hematology & oncology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 109 payments — averaging $1367.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$123K
- Genentech, Inc.$6K
- Foundation Medicine, Inc.$6K
- Fosun Pharma USA Inc.$5K
- Takeda Pharmaceuticals U.S.A., Inc.$4K
- AstraZeneca$3K
- plus $2K from 4 others
Across 64 payments — averaging $3139.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$75K
- Genentech, Inc.$70K
- EMD Serono, Inc.$37K
- AbbVie$14K
- Bayer$4K
What the payments were for
- Consulting fees$20,05013%
- Speaking & faculty fees$98,13066%
- Travel & lodging$22,52115%
- Food & beverage$8,2046%
- Education$1360%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 78 | $123,068 |
| Genentech, Inc. | 6 | $5,855 |
| Foundation Medicine, Inc. | 5 | $5,654 |
| Fosun Pharma USA Inc. | 9 | $5,427 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $4,341 |
| AstraZeneca | 3 | $2,601 |
| Sanofi | 1 | $1,875 |
| Jazz Pharmaceuticals Inc. | 1 | $145 |
| Lilly USA, LLC | 1 | $41 |
| Roche Diagnostics Corporation | 1 | $33 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TECENTRIQ$85,056
- Non-Covered Product$12,856
- ROZLYTREK$9,973
- Alecensa$7,526
- FOUNDATIONACT$5,604
- FOUNDATIONFOCUS$5,604
- FOUNDATIONONE CDX$5,604
- FOUNDATIONONE HEME$5,604
- FOUNDATIONONE$5,604
- ALUNBRIG$4,262
- LIBTAYO$1,875
- Avastin$239
- ZEPZELCA$145
How this compares
$149,041 in reported general payments places this provider in the 95th percentile of 682 hematology & oncology providers in Pennsylvania.
Other hematology & oncology in Hershey
- Kevin RakszawskiHershey$237K
- Jeffrey PuHershey$103K
- Cristina TruicaHershey$102K
- David NguyenHershey$81K
- Joseph DrabickHershey$53K
- Patrick MaHershey$42K
- Salman FazalPittsburgh$2.3M
- Cyrus KhanPittsburgh$1.9M
- Usama GergisAllentown$1.2M
- Kit LuHarrisburg$810K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.